Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study

Journal of the American Society of Nephrology

Volumn 12, Issue 12, 2001, Pages 2759-2767

  London, G M ^a   Pannier, B ^a   Guerin, A P ^a   Blacher, J ^a   Marchais, S J ^a   Darne, B ^a   Metivier, F ^a   Adda, H ^a   Safar, M E ^a  

^a Hôpital F H Manhes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHILD; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL;

EID: 0035195246     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v12122759     Document Type: Article

References (45)

1. Report on management of renal failure in Europe, XXII, 1991
2. Cardiovascular function in hemodialysis patients
3. Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients
4. Impact of left ventricular hypertrophy on survival in end-stage renal disease
5. Outcome and risk factors for left ventricular disorders in chronic uremia
6. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
7. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
8. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
9. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
10. Cardiac and arterial interactions in end-stage renal disease
11. Pressure-overload cardiomyopathy in end-stage renal disease
12. Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients
13. Endothelin and cardiovascular remodelling in end-stage renal disease
14. Cardiac disease in chronic uremia: Pathogenesis
15. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
16. The clinical course of left ventricular hypertrophy in dialysis patients
17. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation
18. Long-term evolution of cardiomyopathy in dialysis patients
19. Serial changes in echocardiographic parameters and cardiac failure in end-stage renal disease
20. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade
21. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects
22. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
23. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uremic patients
24. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
25. Salt and water retention and calcium blockade in uremia
26. Aortic and large artery compliance in end-stage renal disease
27. The meaning and use of the area under a receiver operating characteristic (ROC) curve
28. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass. Quantification and clinical implications
29. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors: The Framingham Heart Study
30. Prognostic significance of serial changes in left ventricular mass in essential hypertension
31. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
32. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
33. Vascular impedance
34. Mechanical principles in arterial disease
35. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease
36. Impact of aortic stiffness on survival in end-stage renal disease
37. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease
38. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population
39. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
40. Increased stiffness of radial artery wall material in end-stage renal disease
41. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin
42. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging
43. The reliability and validity of echocardiographic measurements of left ventricular mass index in hemodialysis patients
44. How reliable are serial echocardiographic measurements in detecting regression in left ventricular hypertrophy and changes in function?